Nervous system regulation
"If you need to drop the dose and then expand the frequency, to taking it maybe once a month, once every other week, the key is keeping you at that healthy weight in the safest, most efficacious way we can do it." Editor's note: This story was originally published on May 19, 2023.
GLP-1 and dual GIP/GLP-1 agonists have brought new hope for people living with obesity who havent found success with lifestyle changes alone
The Promise of GLP-1 Drugs: More Than Just Diabetes Management When GLP-1 (Glucagon-Like Peptide-1) receptor agonists first hit the market, they were hailed as a breakthrough in type 2 diabetes
Sin embargo, las directrices tambin establecen que "la medicacin por s sola no puede resolver la carga mundial de la obesidad"
This fatigue can be due to various causes, including alterations in metabolic processes, loss of appetite, gastrointestinal disturbances, and hormone imbalances